Growth Metrics

Biomarin Pharmaceutical (BMRN) Retained Earnings: 2009-2024

Historic Retained Earnings for Biomarin Pharmaceutical (BMRN) over the last 16 years, with Dec 2024 value amounting to -$194.7 million.

  • Biomarin Pharmaceutical's Retained Earnings rose 162.81% to $200.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $200.8 million, marking a year-over-year increase of 162.81%. This contributed to the annual value of -$194.7 million for FY2024, which is 68.68% up from last year.
  • Biomarin Pharmaceutical's Retained Earnings amounted to -$194.7 million in FY2024, which was up 68.68% from -$621.6 million recorded in FY2023.
  • In the past 5 years, Biomarin Pharmaceutical's Retained Earnings ranged from a high of -$194.7 million in FY2024 and a low of -$930.8 million during FY2021.
  • Its 3-year average for Retained Earnings is -$535.1 million, with a median of -$621.6 million in 2023.
  • Per our database at Business Quant, Biomarin Pharmaceutical's Retained Earnings decreased by 8.03% in 2021 and then surged by 68.68% in 2024.
  • Over the past 5 years, Biomarin Pharmaceutical's Retained Earnings (Yearly) stood at -$861.6 million in 2020, then dropped by 8.03% to -$930.8 million in 2021, then increased by 15.21% to -$789.2 million in 2022, then climbed by 21.24% to -$621.6 million in 2023, then spiked by 68.68% to -$194.7 million in 2024.